Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Guy Buckle

Neurology Brookline, MA Medical Doctor

NPI 1861404642 CMS profile 357201

One Brookline Place, Partners Multiple Sclerosis Center, Brookline, MA 02445

Open in the dashboard

General payments

$449,917

518 records reported · program years 2019–2024

Research payments

$1,864

Paid to them · 5 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$500 paid to institutions, not to them · program year 2023

Through program year 2024, Guy Buckle of Brookline, MA is reported in the CMS Open Payments database as having received $449,917 across 518 general payments and $1,864 in research payments paid to them. Separately, studies naming them as principal investigator received $500 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $26 1
2021 General $28,882 20
2020 General $62,303 84
2019 General $358,706 413
2019 Research $1,864 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Guy Buckle
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Guy Buckle were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Guy Buckle Neurology median Middle half National median
2019 $358,706 $474 $118–$2,177 $163
2020 $62,303 $367 $82–$2,309 $114
2021 $28,882 $438 $104–$2,547 $132
2022 $0 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $26 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. EMD Serono, Inc. $96,471 135 payments
  2. Novartis Pharmaceuticals Corporation $78,384 74 payments
  3. Biogen, Inc. $75,460 67 payments
  4. Alexion Pharmaceuticals, Inc. $59,382 70 payments
  5. Genzyme Corporation $51,472 60 payments
  6. Genentech USA, Inc. $39,037 47 payments
  7. Celgene Corporation $37,072 48 payments
  8. Teva Pharmaceuticals USA, Inc. $11,143 7 payments
  9. Ge Healthcare $1,156 2 payments
  10. Amgen Inc. $113 1 payment
  11. Other $226 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $245,976 90 payments
  2. Consulting Fee $146,533 34 payments
  3. Travel and Lodging $46,326 167 payments
  4. Food and Beverage $11,045 224 payments
  5. Education $37 3 payments
Products named General payments · program years 2019–2024
  1. Mavenclad Neurology $49,721 77 payments
  2. AUBAGIO $48,950 54 payments
  3. MAYZENT $44,726 36 payments
  4. TYSABRI $44,317 33 payments
  5. OCREVUS $39,081 49 payments
  6. Ozanimod $20,602 30 payments
  7. ZEPOSIA $16,514 20 payments
  8. Mavenclad Neurology $15,191 28 payments
  9. TECFIDERA $12,811 12 payments
  10. Rebif $11,219 20 payments
  11. Other $43,456 52 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Novartis Pharmaceuticals Corporation $1,864 5 payments

Records

523 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record